Search results
SF wastewater levels show spike in COVID-19
The San Francisco Examiner· 2 hours ago“In summer 2023, we saw wastewater concentrations for SARS-CoV-2 start to increase in mid-June and peak during August,” she told The ...
COVID can seriously damage your vision, even if you didn’t have symptoms, new study says. Experts...
Fortune via AOL· 7 days agoThough the blood-retinal barrier of people with compromised immune systems is...bacteria and...
Long COVID Risk Factors Revealed In Data From Nearly 5,000 People
IFLScience· 8 hours agoLong COVID describes a chronic condition that is present for at least three months after an...
Invivyd reports antibody neutralization of new COVID variants By Investing.com
Investing.com· 3 days agoInvivyd, Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced today that its investigational...
Wastewater surveillance reveals pathogens in Detroit’s population, helping monitor and predict...
The Conversation via Yahoo News· 5 days agoDetecting infectious agents in sewage is only the first step. Researchers are working on developing...
The National Academy of Sciences issues a damning report on Long COVID in the United States
World Socialist Web Site· 4 days agoIn the statement of tasks, the SSA wrote that the Academy...term disability that may result from...
Bird Flu Pandemic Just “A Question Of When”, Says Ex-CDC Director
IFLScience· 11 hours agoA former director of the Centers for Disease Control and Prevention (CDC) told a US cable news...
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat...
Digital Journal· 5 days agoFood & Drug Administration (“FDA”) for the evaluation of a proposed clinical study of Bucillamine, an oral thiol-based drug with anti-inflammatory and antiviral properties, as a potential < ...
National Academies Issue New Broad Definition of Long COVID
Medscape· 7 days agoAccording to the 2024 NASEM definition of long COVID issued on June 11, 2024, "Long COVID is an...
Xencor (NASDAQ:XNCR) Price Target Cut to $40.00 by Analysts at Raymond James
ETF DAILY NEWS· 3 days agoXencor (NASDAQ:XNCR – Free Report) had its target price lowered by Raymond James from $58.00 to $40.00 in a research report report published on Friday, Benzinga reports. The firm currently has ...
